Ora President and CEO Stuart Abelson was recently interviewed for PharmaVoice Magazine. In the article, he discusses the challenges and opportunities health care companies are facing regarding innovation in clinical trials and product development, including the role of CROs in providing true scientific and operational contribution to a development program.
